Home Screening for imprinting disorders in 58 patients with clinically diagnosed idiopathic short stature
Article
Licensed
Unlicensed Requires Authentication

Screening for imprinting disorders in 58 patients with clinically diagnosed idiopathic short stature

  • Sayaka Kawashima , Hiroko Yagi , Yasuhiro Hirano , Machiko Toki , Kei Izumi , Sumito Dateki , Noriyuki Namba , Tsutomu Kamimaki , Koji Muroya , Toshiaki Tanaka , Maki Fukami ORCID logo , Masayo Kagami ORCID logo EMAIL logo and the Japanese SHOX study group
Published/Copyright: August 31, 2020

Abstract

Objectives

Imprinted genes have important roles for normal growth and development. Imprinting disorders (IDs) such as Silver-Russell syndrome and Temple syndrome are rare diseases that typically cause short children born small for gestational age (SGA). However, some patients with short stature (SS) caused by IDs were born non-SGA. To date, the contribution of IDs to idiopathic short stature (ISS) has been poorly investigated. The aim of this study was to clarify the contribution of IDs to ISS.

Methods

We conducted methylation analysis for 10 differentially methylated regions using pyrosequencing to detect known IDs in 58 patients (31 male and 27 female children, height standard deviation score −4.2 to −2.0) carrying a clinical diagnosis of ISS.

Results

We identified no patient with IDs among these patients with ISS.

Conclusions

These results indicate that IDs are rare in patients having ISS, and that imprinted genes affect fetal growth more than postnatal growth. Because patients with IDs born non-SGA usually have clinical features characteristic of each ID, in addition to SS, the patients with ISS as a clinical diagnosis may not be associated with IDs.

It is unlikely that cases clinically diagnosed with ISS are caused by IDs leading to growth failure.


Corresponding author: Masayo Kagami M.D., Ph.D., Department of Molecular Endocrinology, National Research Institute for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo 157-8535, Japan. Phone: +81 3 3416 0181, Fax: +81 3 5494 7026, E-mail:

Funding source: JCR Pharmaceuticals

Award Identifier / Grant number: 2019B-4

Award Identifier / Grant number: 19ek0109373s0202

Award Identifier / Grant number: 18K06356

Acknowledgments

The authors are grateful to the patients and their family members for their cooperation. The authors also thank Dr. Kolba Clifford Andrew for his editorial assistance with the final draft of this paper. This work was partially supported by a research grant from JCR Pharmaceuticals. This work was supported by grants from the Japan Society for the Promotion of Science (JSPS) (18K06356), the National Center for Child Health and Development (2019B-4), the Japan Agency for Medical Research and Development (AMED) (19ek0109373s0202), and the Takeda Science Foundation.

  1. The Japanese SHOX study group

    M. Adachi (Kanagawa Children’s Medical Center), T. Tajima (Jichi Medical University), T. Tanaka (Tanaka Growth Clinic), O. Arisaka and S. Koyama (Dokkyo Medical University), T. Hamajima (Aichi Children’s Health and Medical Center), O. Nose (Nose Clinic), K. Ozono (Osaka University), N. Namba (Osaka Hospital), K. Nagasaki (Niigata University), T. Kamimaki (Shizuoka City Shimizu Hospital), S. Kanzaki (Tottori University), T. Ogata (Hamamatsu University School of Medicine), H. Tanaka (Okayama Saiseikai General Hospital), Y. Hasegawa (Tokyo Metropolitan Children’s Medical Center), K. Kobayashi (University of Yamanashi), S. Dateki (Nagasaki University), H. Mabe (Kumamoto University), I. Fujiwara (Sendai City Hospital), S. Ida (Osaka Medical Center and Research Institute for Maternal and Child Health), T. Hasegawa (Keio University), A. Uematsu (Shizuoka Children’s Hospital), K. Kashimada (Tokyo Medical and Dental University), K. Onigata (Shimane University), K. Miyako (Fukuoka Children’s Hospital), S. Yokoya (Fukushima Medical University), R. Horikawa (National Center for Child Health and Development), and M. Fukami (National Research Institute for Child Health and Development).

  2. Research funding: MF received a research grant from JCR Pharmaceuticals. This work was also supported by grants from the Japan Society for the Promotion of Science (JSPS) (18K06356), the National Center for Child Health and Development (2019B-4), the Japan Agency for Medical Research and Development (AMED) (19ek0109373s0202), and the Takeda Science Foundation.

  3. Author contributions: Molecular analysis was performed by SK. Detailed clinical data and materials for molecular studies were provided by HY, YH, MT, KI, SD, NN, TK, KM, and TT. The study was designed and coordinated by MK. The paper was written by SK and MK and reviewed and edited by MF.

  4. Competing interests: The funding organization(s) played no role in the study design, in the collection, analysis, and interpretation of data, in the writing of the report, nor in the decision to submit the report for publication.

  5. Informed consent: Informed consent was obtained from all individuals included in this study.

  6. Ethical approval: This study has complied with all the relevant national regulations, institutional policies, and was in accordance with the tenets of the Helsinki Declaration. It has been approved by the Institutional Review Board of the National Center for Child Health and Development, Tokyo, Japan, and was performed after obtaining written informed consent forms from all the participants or legal guardians.

References

1. Dauber, A, Rosenfeld, RG, Hirschhorn, JN. Genetic evaluation of short stature. J Clin Endocrinol Metab 2014;99:3080–92. https://doi.org/10.1210/jc.2014-1506.Search in Google Scholar PubMed PubMed Central

2. Vasques, GA, Andrade, NLM, Jorge, AAL. Genetic causes of isolated short stature. Arch Endocrinol Metab 2019;63:70–8. https://doi.org/10.20945/2359-3997000000105.Search in Google Scholar PubMed

3. Piedrahita, JA. The role of imprinted genes in fetal growth abnormalities. Birth Defects Res A Clin Mol Teratol 2011;91:682–92. https://doi.org/10.1002/bdra.20795.Search in Google Scholar PubMed PubMed Central

4. Cordeiro, A, Neto, AP, Carvalho, F, Ramalho, C, Dória, S. Relevance of genomic imprinting in intrauterine human growth expression of CDKN1C, H19, IGF2, KCNQ1 and PHLDA2 imprinted genes. J Assist Reprod Genet 2014;31:1361–8. https://doi.org/10.1007/s10815-014-0278-0.Search in Google Scholar PubMed PubMed Central

5. Andrade, AC, Lui, JC, Nilsson, O. Temporal and spatial expression of a growth-regulated network of imprinted genes in growth plate. Pediatr Nephrol 2010;25:617–23. https://doi.org/10.1007/s00467-009-1339-y.Search in Google Scholar PubMed

6. Uchimura, T, Hollander, JM, Nakamura, DS, Liu, Z, Rosen, CJ, Georgakoudi, I, et al. An essential role for IGF2 in cartilage development and glucose metabolism during postnatal long bone growth. Development 2017;144:3533–46. https://doi.org/10.1242/dev.155598.Search in Google Scholar PubMed PubMed Central

7. Turner, CL, Mackay, DM, Callaway, JL, Docherty, LE, Poole, RL, Bullman, H, et al. Methylation analysis of 79 patients with growth restriction reveals novel patterns of methylation change at imprinted loci. Eur J Hum Genet 2010;18:648–55. https://doi.org/10.1038/ejhg.2009.246.Search in Google Scholar PubMed PubMed Central

8. Shima, H, Tanaka, T, Kamimaki, T, Dateki, S, Muroya, K, Horikawa, R, et al. Japanese SHOX study group. Systematic molecular analyses of SHOX in Japanese patients with idiopathic short stature and Leri-Weill dyschondrosteosis. J Hum Genet 2016;61:585–9. https://doi.org/10.1038/jhg.2016.18.Search in Google Scholar PubMed

9. Kagami, M, Matsubara, K, Nakabayashi, K, Nakamura, A, Sano, S, Okamura, K, et al. Genome-wide multilocus imprinting disturbance analysis in Temple syndrome and Kagami-Ogata syndrome. Genet Med 2017;19:476–82. https://doi.org/10.1038/gim.2016.123.Search in Google Scholar PubMed PubMed Central

10. Kagami, M, Nagasaki, K, Kosaki, R, Horikawa, R, Naiki, Y, Saitoh, S, et al. Temple syndrome: comprehensive molecular and clinical findings in 32 Japanese patients. Genet Med 2017;19:1356–66. https://doi.org/10.1038/gim.2017.53.Search in Google Scholar PubMed PubMed Central

11. Kawashima, S, Nakamura, A, Inoue, T, Matsubara, K, Horikawa, R, Wakui, K, et al. Maternal uniparental disomy for chromosome 20: physical and endocrinological characteristics of five patients. J Clin Endocrinol Metab 2018;103:2083–8. https://doi.org/10.1210/jc.2017-02780.Search in Google Scholar PubMed

12. Goldstone, AP, Holland, AJ, Hauffa, BP, Hokken-Koelega, AC, Tauber, M. Speakers contributors at the second expert meeting of the comprehensive care of patients with PWS. Recommendations for the diagnosis and management of Prader-Willi syndrome. J Clin Endocrinol Metab 2008;93:4183–97. https://doi.org/10.1210/jc.2008-0649.Search in Google Scholar PubMed

13. Sano, S, Nakamura, A, Matsubara, K, Nagasaki, K, Fukami, M, Kagami, M, et al. (Epi)genotype-phenotype analysis in 69 Japanese patients with pseudohypoparathyroidism type I. J Endocr Soc 2017;2:9–23. https://doi.org/10.1210/js.2017-00293.Search in Google Scholar PubMed PubMed Central

14. Ouni, M, Castell, AL, Rothenbuhler, A, Linglart, A, Bougnères, P. Higher methylation of the IGF1 P2 promoter is associated with idiopathic short stature. Clin Endocrinol (Oxf) 2016;84:216–21. https://doi.org/10.1111/cen.12867.Search in Google Scholar PubMed


Supplementary Material

The online version of this article offers supplementary material (https://doi.org/10.1515/jpem-2020-0198).


Received: 2020-04-17
Accepted: 2020-07-31
Published Online: 2020-08-31

© 2020 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Research Articles
  3. Analysis of the alpha galactosidase gene: mutation profile and description of two novel mutations with extensive literature review in Turkish population
  4. Cascade screening and treatment of children with familial hypercholesterolemia in Turkey
  5. Risk of adrenal insufficiency following intra-articular or periarticular corticosteroid injections among children with chronic arthritis
  6. Vitamin D status is related to severity at onset of diabetes and worse glycemic control
  7. Reassessing vitamin D supplementation in preterm infants: a prospective study and review of the literature
  8. Mutations in PMM2 gene in four unrelated Spanish families with polycystic kidney disease and hyperinsulinemic hypoglycemia
  9. Liraglutide pharmacokinetics and exposure-response in pediatric patients with type 2 diabetes
  10. Identification of nucleotide polymorphism within the NeuroD1 candidate gene and its association with type 1 diabetes susceptibility in Iranian people by polymerase chain reaction-restriction fragment length polymorphism
  11. Prevalence of autoantibodies in type 1 diabetes mellitus pediatrics in Mazandaran, North of Iran
  12. Clinical features of the diabetes eating problem survey–revised Turkish version in children and adolescent with type 1 diabetes
  13. Ambulatory blood pressure profile in office normotensive obese children: prevalence of masked hypertension and impact of parental hypertension
  14. Glycogen storage disease type VI can progress to cirrhosis: ten Chinese patients with GSD VI and a literature review
  15. Short Communication
  16. Screening for imprinting disorders in 58 patients with clinically diagnosed idiopathic short stature
  17. Case Reports
  18. ROHHAD syndrome – A still unrecognized cause of childhood obesity: report of three cases
  19. Carbonic anhydrase VA deficiency: a very rare case of hyperammonemic encephalopathy
  20. Idiopathic infantile hypercalcemia: mutations in SLC34A1 and CYP24A1 in two siblings and fathers
  21. GCK-MODY in a child with cystic fibrosis: the doubt of the treatment plan
Downloaded on 10.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2020-0198/html
Scroll to top button